Introduction of 101 China-based CROs/CMOs serving Western Pharmaceutical and Biotechnology Industry

As Chinese pharmaceutical outsourcing service companies play more and more important roles in today's world pharmaceutical outsourcing industry, it has become increasingly urgent for the Western pharmaceutical and biotechnology companies who plan to outsource any part of their drug discovery, development and manufacturing work to China, to have a complete collection of information with regards to the current service capabilities of the Chinese service providers in order for the outsourcing companies to work with a right partner in China whose service capability ideally matches the requirements of their outsourcing projects. This Introduction is thus designed and prepared to meet this urgent need by the outsourcing companies.

The Introduction compiles the complete information about the service scope and capabilities of 101 China-based service providers that are presently considered the strongest technically in China. These 101 China-based service providers are either capable of conducting contract pharmaceutical research and/or contract chemistry research for drug discovery and development, or have capability to conduct contract manufacturing of bulk materials [active pharmaceutical ingredients (APIs) and/or their intermediates] for drug candidates in development stages.

For each of these 101 China-based CROs/CMOs, the Introduction has examined a total of ten categories to measure their service capabilities. These criteria are considered most important for an outsourcing company to know when looking for a service provider in China. They include:

• 1) Company name
• 2) A full description of each provider's service scope and capability
• 3) Comments about their service features and strengths
• 4) Their facility and capacity
• 5) Their in-house products (compound libraries) ready to offer
• 6) Customers each provider has served so far
• 7) Background of the provider company's founder(s) or its current executive(s) including their scientific/education merits and work experiences
• 8) Year the company was founded
• 9) Current number of technical employees including the percentage of senior (such as Ph.D.) level scientists to reflect their real technical strength
• 10) A complete collection of their contact information including physical and mailing address as well as e-mail addresses, phone and fax numbers, website addresses, and the addresses of their branches or divisions in other places than their headquarters.

The Introduction provides answers to the following questions borne in mind of almost every outsourcing company:

• Where can I find these Chinese service providers
• How do I know what services they are currently offering
• How good is each of them
• How do I know whether they can handle my projects
• Which one could best meet the requirements of my outsourcing projects
• Where are they located in China
• How to approach them

Who should buy this report:

This Introduction best meets the various needs of following companies:

• Pharma/biotech companies who have already had outsourcing activities in China but would like to know more service providers as their backup service candidates.
• Pharma/biotech companies who have been slightly familiar with the Chinese pharmaceutical outsourcing service industry but wish to have a better understanding about this entire industry in China.
• Pharma/biotech companies who are currently in plan to outsource any part of their drug discovery, development and manufacturing work to China.
• Pharma/biotech companies who will consider China as a potential choice for their outsourcing activity in near future.
• Pharma/biotech companies or any other organizations (such as government organizations, market research institutions, etc.) who do not have any outsourcing activities in China but would be interested in closely following the development of this industry in China.
• Financial investment companies who wish to better understand the development situation of the interesting Chinese service providers in order to facilitate their decision making process for potential investment in any of these Chinese service companies.

In addition, the Introduction could also be a useful reference book to those Chinese pharmaceutical companies and those pharmaceutical outsourcing service companies in both the Western countries and China who wish to have a better understanding about their competitors in the same industry as well as about where their own service levels presently stand in the entire world pharmaceutical outsourcing industry in order for them to improve and strengthen their service capabilities.